Susquehanna International Group
VIRS

Susquehanna International Group’s Pacer BioThreat Strategy ETF VIRS Stock Holding History

Susquehanna International Group’s Portfolio VIRS Stock Details VIRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-21,048
Closed -$838K – 13607
2024
Q3 		$838K Sell
21,048
-259
-1% -$9.87K ﹤0.01% 7226
2024
Q2 		$775K Buy
21,307
+602
+3% +$21.5K ﹤0.01% 7184
2024
Q1 		$749K Buy
20,705
+267
+1% +$9.17K ﹤0.01% 7556
2023
Q4 		$660K Buy
20,438
+2,780
+16% +$83.7K ﹤0.01% 7995
2023
Q3 		$527K Buy
17,658
+747
+4% +$23.3K ﹤0.01% 8108
2023
Q2 		$527K Buy
16,911
+586
+4% +$17.5K ﹤0.01% 8188
2023
Q1 		$478K Buy
16,325
+2,707
+20% +$77.6K ﹤0.01% 8677
2022
Q4 		$384K Buy
13,618
+1,021
+8% +$28.2K ﹤0.01% 8484
2022
Q3 		$317K Buy
+12,597
New +$346K ﹤0.01% 9662

Susquehanna International Group's VIRS Position: Q4 2024 in Review

Susquehanna International Group sold out of Pacer BioThreat Strategy ETF (VIRS) in Q4 2024, closing a stake of 21,048 shares — an estimated $838K sold.

Susquehanna International Group first reported a position in VIRS in Q3 2022 and held it in 9 quarters. The position peaked at $838K in Q3 2024. 0 funds tracked by Wall St. Rank hold VIRS as of Q4 2024.

  • Susquehanna International Group reported no remaining Pacer BioThreat Strategy ETF position as of Q4 2024 after selling out during the quarter.
  • Susquehanna International Group sold 21,048 Pacer BioThreat Strategy ETF shares in Q4 2024, an estimated $838K.
  • Susquehanna International Group first reported a position in Pacer BioThreat Strategy ETF in Q3 2022 and held it in 9 quarters.
  • Susquehanna International Group's Pacer BioThreat Strategy ETF position peaked at $838K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Pacer BioThreat Strategy ETF as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.